Three types of highly promising small RNA therapeutics, namely, small interfering RNAs
(siRNAs), microRNAs (miRNAs) and the RNA subtype of antisense oligonucleotides (ASOs) …

Natural products (NPs) have long been used as a rich source of bioactive compounds for
drug development. Recent technological advancements have revitalised natural products …

Abstract Background and Purpose MicroRNA (miR)‐210 function in endothelial cells and its
role in diabetes‐associated endothelial dysfunction are not fully understood. We aimed to …

Abstract Background and Purpose To date, there are limited options for severe Coronavirus
disease 2019 (COVID‐19), caused by SARS‐CoV‐2 virus. As ADP‐ribosylation events are …

Background and Purpose Inhibitors of histone deacetylases (iHDACs) are promising drugs
for neurodegenerative diseases. We have evaluated the therapeutic potential of the new …

Abstract Background and Purpose Chitinase‐3‐like 1 (CHI3L1) causes skin inflammation in
the progression of atopic dermatitis. We investigated if anti‐CHI3L1 antibody could prevent …

Background and purpose Maintaining mitochondrial quality is attracting attention as a new
strategy to treat diabetes and diabetic complications. We previously reported that …

Background and Purpose The ability to measure specific molecules at multiple sites within
the body simultaneously, and with a time resolution of seconds, could greatly advance our …

In recent years, various approaches have been undertaken to eliminate lipoproteins co‐
isolated with extracellular vesicles, as they were initially regarded as contaminating entities …

Background and Purpose Traditional Chinese medicine (TCM) played an important role in
controlling the COVID‐19 pandemic, but the scientific basis and its active ingredients are still …